This episode currently has no reviews.
Submit ReviewStocks selling off as investors digested this morning’s stronger than expected jobs report. And with nearly all of the post-election gains fading, with next week’s inflation data cause even more volatility? Plus Obesity drugs expected to be in focus at this year’s JPMorgan Health Care conference. How the industry’s biggest names are handling competition, and the next-generation of weight loss drugs.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review